TABLE 1.

Clinical Trial Publication Characteristics and Associations Containing Stigmatizing Terminology for Outcomes and Processes (STOP)

Article Characteristics	Articles With STOP (115) No. (%)	Articles Without STOP (32) No. (%)	Total (147) No. (%)	OR (95% CI)	AOR (95% CI)
Type of intervention
Behavioral	58 (50.43)	15 (46.88)	73 (49.66)	1 (Ref)	1 (Ref)
Device	18 (15.65)	7 (21.88)	25 (17.01)	1.5 (0.53–4.26)	2.07 (0.67–6.4)
Pharmacologic	35 (30.43)	10 (31.25)	45 (30.61)	1.1 (0.45–2.73)	1.19 (0.43–3.29)
Other	4 (3.48)	0 (0)	4 (2.72)	1 -	1 -
Article funding
Grant	94 (81.74)	23 (71.88)	117 (79.59)	1 (Ref)	1 (Ref)
Industry	3 (2.61)	1 (3.13)	4 (2.72)	1.36 (0.14–13.71)	1.64 (0.14–18.53)
No funding	2 (1.74)	0 (0)	2 (1.36)	—	—
No Statement	12 (10.43)	5 (15.63)	17 (11.56)	1.7 (0.55–5.32)	1.41 (0.42–4.8)
Public	4 (3.48)	3 (9.38)	7 (4.76)	3.07 (0.64–14.66)	6.83 (0.97–48.05)
Mention of CONSORT
No	74 (64.35)	23 (71.88)	97 (65.99)	1 (Ref)	1 (Ref)
Yes	41 (35.65)	9 (28.13)	50 (34.01)	0.71 (0.3–1.67)	0.64 (0.24–1.68)
First author employment
Government	14 (12.17)	4 (12.5)	18 (12.24)	1 (Ref)	1 (Ref)
Private	25 (21.74)	5 (15.63)	30 (20.41)	0.7 (0.16–3.04)	0.69 (0.14–3.29)
Public	74 (64.35)	23 (71.88)	97 (65.99)	1.07 (0.32–3.58)	0.97 (0.27–3.5)
Journal requires AMA/ICMJE guidelines
Government	32 (27.83)	12 (37.5)	44 (29.93)	1 (Ref)	1 (Ref)
Private	83 (72.17)	20 (62.5)	103 (70.07)	0.64 (0.28–1.46)	0.6 (0.25–1.44)
Journal H-index*
Mean (SD)	132.42 (64.97)	123.75 (61.58)	130.53 (64.14)	1 (0.99–1)	1 (0.99–1.01)

*H-index from Scientific Journal Rankings (https://www.scimagojr.com/journalrank.php) current as of July 21, 2021.

CI indicates confidence interval; CONSORT, CONsolidated Standards Of Reporting Trials; OR. odds ratio.